检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]湖北省妇幼保健院急诊科,湖北武汉430070
出 处:《贵州医药》2017年第1期20-22,共3页Guizhou Medical Journal
摘 要:目的探讨特应性皮炎(AD)患儿外周血白细胞介素-17(IL-17)、白细胞介素-8(IL-8)、免疫球蛋白E(IgE)及嗜酸性粒细胞计数(EOS)的水平变化及其意义。方法选取120例AD患儿作为AD组,以同期30名健康儿童作为对照组,检测并比较两组外周血IL-17、IL-8、IgE及EOS的水平,依据皮损严重程度对AD患儿进行分层分析。结果 AD组患儿的外周血中IL-17、IL-8、IgE及EOS水平均显著高于对照组(P<0.05);AD组患儿的外周血中IL-17、IL-8、IgE、EOS水平及AD严重程度评分各亚组间比较,重度组>中度组>轻度组,且差异具有统计学意义(P<0.05);AD组患儿的外周血中IL-17、IL-8、IgE、EOS水平与AD严重程度评分均呈显著正相关(P<0.05)。结论 AD儿童外周血IL-17、IL-8、IgE及EOS水平均显著的增高,且与病情严重程度密切相关。Objective To investigate the changes and significance of IL-17, IL-8, serum IgE and EOS levels in peripheral blood of children with AD. Methods Selected the Zhengzhou Children's Hospital in January 2011 -- De- cember 2015 outpatient diagnosis and treatment of 120 patients with AD children (AD group), over the same period 40 cases of healthy children as a control group, the levels of EOS, IL-8, IgE and IL-17 in peripheral blood of two groups were detected and compared, according to the severity of skin lesions in children with AD stratified analysis. Results The peripheral blood of AD patients IL-17, IL-8, IgE and EOS levels were significantly higher than the con- trol group and there were statistical significantly differences (P〈0.05). IL-17, IL-8, IgE, EOS levels and AD se- verity score in the peripheral blood of AD group were compared among the subgroups, the severe group moderate group 〉 mild group and there were statistical significantly differences (P〈0.05). The levels of, IL-17, IL-8, IgE and EOS were significantly positively correlated with the AD severity scores (P〈0.05) in the peripheral blood of children with AD. Conclusion IL-17, IL-8, IgE and EOS levels were significantly higher in AD children, and it is closely related to the pathogenesis and severity of the disease.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.147